Cyendiv (Nintedanib)
Price range: $490 through $1,520Cyendiv (Nintedanib Capsules) delivers nintedanib, an oral inhibitor targeting multiple tyrosine kinases including VEGFR, PDGFR, and FGFR. It slows disease progression in idiopathic pulmonary fibrosis (IPF) and, combined with chemotherapy, treats advanced non-small cell lung cancer (NSCLC) under specialist supervision.


